Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
Cerilliant
McKinsey
Farmers Insurance
US Army
Cantor Fitzgerald
Merck
Daiichi Sankyo

Generated: May 27, 2018

DrugPatentWatch Database Preview

Valeant Pharm Intl Company Profile

« Back to Dashboard

What is the competitive landscape for VALEANT PHARM INTL, and what generic and branded alternatives to VALEANT PHARM INTL drugs are available?

VALEANT PHARM INTL has forty-four approved drugs.



Summary for Valeant Pharm Intl
US Patents:0
Tradenames:37
Ingredients:32
NDAs:44

Drugs and US Patents for Valeant Pharm Intl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl EFUDEX fluorouracil CREAM;TOPICAL 016831-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl ANDROID 5 methyltestosterone TABLET;BUCCAL 087222-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl ELDECORT hydrocortisone CREAM;TOPICAL 080459-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharm Intl EFUDEX fluorouracil SOLUTION;TOPICAL 016831-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Valeant Pharm Intl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl PERMAX pergolide mesylate TABLET;ORAL 019385-003 Dec 30, 1988 5,114,948 ➤ Try a Free Trial
Valeant Pharm Intl VIRAZOLE ribavirin FOR SOLUTION;INHALATION 018859-001 Dec 31, 1985 4,211,771 ➤ Try a Free Trial
Valeant Pharm Intl DALMANE flurazepam hydrochloride CAPSULE;ORAL 016721-002 Approved Prior to Jan 1, 1982 4,316,897 ➤ Try a Free Trial
Valeant Pharm Intl LIBRELEASE chlordiazepoxide CAPSULE, EXTENDED RELEASE;ORAL 017813-001 Sep 12, 1983 4,316,897 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for VALEANT PHARM INTL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Inhalation Solution 6 gm/vial ➤ Subscribe 2014-05-22
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Dow
Queensland Health
Covington
Johnson and Johnson
Farmers Insurance
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.